Literature DB >> 19632897

Dry-powder pulmonary insufflation in the mouse for application to vaccine or drug studies.

Melissa Morello1, Cassandra L Krone, Shelley Dickerson, Elizabeth Howerth, Willem Andreas Germishuizen, Yun-Ling Wong, David Edwards, Barry R Bloom, Mary K Hondalus.   

Abstract

Pulmonary delivery of substances in small animal models is often useful for experimental testing of various vaccine and drug candidates. One of the most challenging elements to such protocols is the efficient disposition of test materials in the lungs of mice. Herein we detail a means to deliver dry powders of an inhalant live-attenuated Mycobacterium bovis Bacille Calmette-Guerin (BCG) vaccine against Mycobacterium tuberculosis to the lungs of mice. The direct delivery methodology is quick, safe, and allows for repeated pulmonary insufflation of substances if boosting is desired. This model system could be easily adapted for use with other dry-powder vaccine and drug candidates.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19632897     DOI: 10.1016/j.tube.2009.07.001

Source DB:  PubMed          Journal:  Tuberculosis (Edinb)        ISSN: 1472-9792            Impact factor:   3.131


  15 in total

1.  Use of Computational Fluid Dynamics (CFD) Dispersion Parameters in the Development of a New DPI Actuated with Low Air Volumes.

Authors:  Worth Longest; Dale Farkas; Karl Bass; Michael Hindle
Journal:  Pharm Res       Date:  2019-05-28       Impact factor: 4.200

2.  Pulmonary Delivery of Magnetically Targeted Nano-in-Microparticles.

Authors:  Amber A McBride; Dominique N Price; Pavan Muttil
Journal:  Methods Mol Biol       Date:  2017

3.  Disposable Dosators for Pulmonary Insufflation of Therapeutic Agents to Small Animals.

Authors:  Phillip G Durham; Shumaila N Hanif; Lucia Garcia Contreras; Ellen F Young; Miriam S Braunstein; Anthony J Hickey
Journal:  J Vis Exp       Date:  2017-03-30       Impact factor: 1.355

4.  Pulmonary Pharmacokinetics of Colistin following Administration of Dry Powder Aerosols in Rats.

Authors:  Yu-Wei Lin; Qi Tony Zhou; Yang Hu; Nikolas J Onufrak; Siping Sun; Jiping Wang; Alan Forrest; Hak-Kim Chan; Jian Li
Journal:  Antimicrob Agents Chemother       Date:  2017-10-24       Impact factor: 5.191

5.  Development of a New Inhaler for High-Efficiency Dispersion of Spray-Dried Powders Using Computational Fluid Dynamics (CFD) Modeling.

Authors:  Worth Longest; Dale Farkas
Journal:  AAPS J       Date:  2019-02-07       Impact factor: 4.009

6.  Aerosol Delivery of siRNA to the Lungs. Part 1: Rationale for Gene Delivery Systems.

Authors:  Susanne R Youngren-Ortiz; Nishant S Gandhi; Laura España-Serrano; Mahavir B Chougule
Journal:  Kona       Date:  2015-09-30       Impact factor: 2.897

7.  Albumin-coated porous hollow poly(lactic-co-glycolic acid) microparticles bound with palmityl-acylated exendin-4 as a long-acting inhalation delivery system for the treatment of diabetes.

Authors:  Hyunuk Kim; Juho Lee; Tae Hyung Kim; Eun Seong Lee; Kyung Taek Oh; Don Haeng Lee; Eun-Seok Park; You Han Bae; Kang Choon Lee; Yu Seok Youn
Journal:  Pharm Res       Date:  2011-04-07       Impact factor: 4.200

8.  Pulmonary distribution of nanoceria: comparison of intratracheal, microspray instillation and dry powder insufflation.

Authors:  Ramon M Molina; Nagarjun V Konduru; Hugo Hirano; Thomas C Donaghey; Benoit Adamo; Brendan Laurenzi; Georgios Pyrgiotakis; Joseph D Brain
Journal:  Inhal Toxicol       Date:  2016-09-12       Impact factor: 2.724

9.  Inhalation Exposure to Carbon Nanotubes (CNT) and Carbon Nanofibers (CNF): Methodology and Dosimetry.

Authors:  Günter Oberdörster; Vincent Castranova; Bahman Asgharian; Phil Sayre
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2015       Impact factor: 6.393

10.  Btk Inhibitor RN983 Delivered by Dry Powder Nose-only Aerosol Inhalation Inhibits Bronchoconstriction and Pulmonary Inflammation in the Ovalbumin Allergic Mouse Model of Asthma.

Authors:  Jonathan E Phillips; Lorena Renteria; Lisa Burns; Paul Harris; Ruoqi Peng; Carla M T Bauer; Dramane Laine; Christopher S Stevenson
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2016-04-25       Impact factor: 2.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.